Navigation Links
SphygmoCor Px Central Blood Pressure Assessment and Management System

ProductsSphygmoCor Px Central Blood Pressure Assessment and Management System
Company AtCor Medical Pty Ltd.
Item SphygmoCor Px Central Blood Pressure Assessment and Management System
Features The SphygmoCor Px Central Blood Pressure Assessment and Management System has transformed cardiovascular evaluation, enhancing patient assessment and management by providing the following information:
  • Evaluation of systemic arterial stiffness (Aortic Augmentation Index) and its clinical impact on the heart in increasing patient risk of heart failure, stroke and myocardial ischaemia.
  • Augmentation pressure, which drives left ventricular load (afterload) - a key parameter affecting risk of LV hypertrophy.
  • Central Pulse pressure in the ascending aorta (driving cerebral blood flow) giving the true pressure, and hence the risk of stroke.
  • Central systolic pressure, often markedly different from the cuff value.
  • Ejection duration a parameter for distinguishing primarily systolic from primarily diastolic dysfunction, and for managing the efficacy of heart failure therapy.
  • Diastolic pressure-time index (DPTI), a key determinant of coronary blood supply.
  • Systolic pressure-time index (SPTI), a measure of myocardial oxygen demand.
  • Subendocardial Viability Ratio the relationship of DPTI and SPTI, providing a powerful index for risk stratification for myocardial ischaemia.
Description The SphygmoCor Px Central Blood Pressure Assessment and Management System provides a quick and non-invasive method of obtaining central blood pressure and other key cardiovascular data, and is intended to enhance the treatment and management of patients.

Using a validated generalized transfer function, the system derives the ascending aortic blood pressure waveform from the radial arterial pressure waveform. SphygmoCor then analyzes the central aortic waveform to central pressures and other provide key indices of arterial stiffness and cardiovascular risk. These indices include aortic augmentation pressure, aortic augmentation index, ejection duration, and Buckberg Index (subendocardial viability ratio). Data are reported against age- and gender-specific reference normals.

Info AtCor Medical Pty Ltd.
Customer Service: (630) 799-8217
Web site: http://www.atcormedical.com/

Related medicine products :

1. SphygmoCor Vx Central Blood Pressure/Pulse Wave Velocity System
2. SphygmoCor Mx Central Blood Pressure Monitoring System
3. SphygmoCor Px Pulse Wave Analysis System test
4. Innotrac Aio! Central
5. Endoalpha Centralized O.R. Control System
6. Centralized Holter Analysis
7. S/5 iCentral
8. Acuity LT Central Station
9. Mobile Acuity LT™ Central Station
10. Acuity® Central Station
11. Oxinet III Central Station Network
...
For the qualitative detection of human occult blood in fecal specimens....
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
For the measurement of vaginal pH as part of a self examination programme to help reduce the risk of pre-term birth...
Medicine Products:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of ... collection of specialty vendors and unique items from across the nation, this holiday-themed event ... wellness services offered by the VNA. The boutique will be open Saturday, November ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite ... program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: